Status:

RECRUITING

Peripheral Interfaces in Amputees for Sensorimotor Integration

Lead Sponsor:

VA Office of Research and Development

Collaborating Sponsors:

United States Department of Defense

Congressionally Directed Medical Research Programs

Conditions:

Upper Extremity Amputee

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

The purpose of this research is to gather information on the safety and effectiveness of an implanted wireless sensory enabled highly intuitive controlled prosthetic device.

Detailed Description

The study involves a surgical implant of cuff electrodes on the residual nerves in the amputated limb, and muscle recording electrodes in muscles. These will be connected to an implanted stimulator. T...

Eligibility Criteria

Inclusion

  • Age 21 or greater
  • Acquired upper limb amputation
  • Unilateral or bilateral amputation, Above or below elbow
  • At least 6 months since time of amputation
  • Current user of a myoelectric prosthesis or prescribed to use one
  • Viable target nerves in the upper extremity \*
  • Recommendation from a psychologist following a psychological assessment that the subject is mentally competent and capable of completing the study related activities

Exclusion

  • A contraindication preventing surgery
  • Uncontrolled diabetes
  • Chronic skin ulcerations
  • History of poor wound healing without specific cause
  • History of uncontrolled infection without specific cause
  • Active infection
  • Pregnancy or women of childbearing potential unwilling to prevent pregnancy during participation in the study
  • Inability to speak English
  • Expectation that MRI will be required at any point for duration of study or while device is implanted.
  • Arthritis in the area of implant
  • Individuals with active implantable medical devices or individuals that use external active medical devices that are medically necessary and/or life-supporting or life-sustaining (e.g. insulin pumps, ventilators)
  • Presence of auto immune diseases, or conditions requiring immunosuppression.

Key Trial Info

Start Date :

August 18 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2032

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT04430218

Start Date

August 18 2020

End Date

June 30 2032

Last Update

August 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, United States, 44106-1702